Christian Angermeyer is an entrepreneur and investor and founder of Apeiron Investment Group.
March 4, 2021
/PRNewswire/ -- nextmarkets, the innovative and commission-free online broker, receives $30 million in a Series B financing round. The additional capital is...
March 3, 2021
Berlin-headquartered biotech firm Atai Life Sciences has raised $157m amid the global race to commercialise psychedelics.
December 21, 2020
/PRNewswire/ -- Peptilogics announced today the closing of a $35.4 million Series B financing. The financing was led by Presight Capital, with participation...
Amirah Al Idrus
November 23, 2020
ATAI Life Sciences is topping off a busy year with a $125 million financing, which will support the preclinical and clinical development for its mental health pipeline, including programs in opioid use disorder and depression. The series C round follows a $43 million round in March 2019.
November 16, 2020
Christian Angermayer has been one of the investors most resonsible for the global psychedelic renaissance with Compass Pathways and Atai Life Sciences.